"Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: A comprehensive genotype-phenotype correlation study," Histopathology (Vol: 61, Issue: 5, Page 801-809) - 2012
"Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1," American Journal of Hypertension (Vol: 25, Issue: 10, Page 1118-1123) - 2012
"Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs," Medical Oncology (Vol: 29, Issue: 3, Page 1765-1772) - 2012
"Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia," Leukemia (Vol: 26, Issue: 9, Page 2144-2146) - 2012
"Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors," Clinical Cancer Research (Vol: 18, Issue: 16, Page 4375-4384) - 2012
"Multiplex mutation screening by mass spectrometry in gastrointestinal stromal tumours," Pathology (Vol: 44, Issue: 5, Page 460-464) - 2012
"Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors," Molecular Cancer Therapeutics (Vol: 11, Issue: 8, Page 1770-1780) - 2012
"Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)," Annals of Surgical Oncology (Vol: 19, Issue: 7, Page 2420-) - 2012
"Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: A multicenter phase II trial," Journal of Clinical Oncology (Vol: 30, Issue: 19, Page 2401-2407) - 2012
"Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132," Annals of Surgical Oncology (Vol: 19, Issue: 4, Page 1074-1080) - 2012
"Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours," Histopathology (Vol: 59, Issue: 6, Page 1071-1080) - 2011
"Neurofibromatosis type 1-associated wild-type gastrointestinal stromal tumor treated with anti-IGF-1R monoclonal antibody," Medical Oncology (Vol: 28, Issue: SUPPL. 1, Page S162-S164) - 2011
"Gastrointestinal stromal tumours: Origin and molecular oncology," Nature Reviews Cancer (Vol: 11, Issue: 12, Page 865-878) - 2011
"Multiplex Mutation screening by mass spectrometry: Evaluation of 820 cases from a personalized cancer medicine registry," Journal of Molecular Diagnostics (Vol: 13, Issue: 5, Page 504-513) - 2011
"In response," American Journal of Surgical Pathology (Vol: 35, Issue: 8, Page 1247-1248) - 2011
"SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing," Journal of the National Cancer Institute (Vol: 103, Issue: 12, Page 983-987) - 2011
"The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3β-dependent pathway.," Molecular cancer therapeutics (Vol: 10, Issue: 6, Page 949-959) - 2011
"The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3b-dependent pathway," Molecular Cancer Therapeutics (Vol: 10, Issue: 6, Page 649-659) - 2011
""Pediatric-type" gastrointestinal stromal tumors in adults: Distinctive histology predicts genotype and clinical behavior," American Journal of Surgical Pathology (Vol: 35, Issue: 4, Page 495-504) - 2011
"Immunohistochemical and molecular markers in breast phyllodes tumors," Applied Immunohistochemistry and Molecular Morphology (Vol: 19, Issue: 2, Page 119-125) - 2011
